Your browser doesn't support javascript.
loading
Minocycline and the risk of acute psychiatric events in adolescence: A self-controlled case series.
Brauer, Ruth; Herrero-Zazo, Maria; Barlow, David J; Gaughran, Fiona; Taylor, David; Howard, Louise M.
Affiliation
  • Brauer R; 1 Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Herrero-Zazo M; 2 Research Department of Practice and Policy, School of Pharmacy, University College London, London, UK.
  • Barlow DJ; 3 Department of Pharmacy and Forensic Science, Institute of Pharmaceutical Science, King's College London, London, UK.
  • Gaughran F; 3 Department of Pharmacy and Forensic Science, Institute of Pharmaceutical Science, King's College London, London, UK.
  • Taylor D; 1 Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Howard LM; 4 South London and Maudsley NHS Foundation Trust, London, UK.
J Psychopharmacol ; 33(4): 466-471, 2019 04.
Article in En | MEDLINE | ID: mdl-30696331
ABSTRACT

BACKGROUND:

Minocycline has neurological anti-inflammatory properties and has been hypothesised to have antipsychotic effects.

AIM:

The aim of this study was to investigate, using routinely collected United Kingdom primary health care data, whether adolescent men and women are more or less likely to receive an urgent psychiatric referral during treatment for acne with minocycline compared with periods of non-treatment.

METHOD:

A self-controlled case series using United Kingdom Clinical Practice Research Datalink to calculate the incidence rate ratio of urgent psychiatric referrals for individuals, comparing periods during which minocycline was prescribed with unexposed periods, adjusted for age.

RESULTS:

We found 167 individuals who were at the time exposed to minocycline for a mean of 99 days and who received an urgent psychiatric referral. There was no difference in psychiatric referral risk during periods of exposure compared with periods of non-exposure incidence rate ratio first 6 weeks of exposure 1.96, 95% confidence interval 0.82-4.71, p=0.132; incidence rate ratio remaining exposure period=1.97, 95% confidence interval 0.86-4.47, p=0.107.

CONCLUSIONS:

We found no evidence in support of a protective effect of minocycline against severe psychiatric symptoms in adolescence.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Referral and Consultation / Acne Vulgaris / Mental Disorders / Minocycline Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: J Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2019 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Referral and Consultation / Acne Vulgaris / Mental Disorders / Minocycline Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: J Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2019 Document type: Article Affiliation country: United kingdom